Source: Reason
by JD Tuccille
“Price controls and regulatory burdens make the market unattractive for pharmaceutical companies.” (02/20/26)
https://reason.com/2026/02/20/canadas-government-dominated-healthcare-chokes-access-to-new-drugs/
Source: Reason
by JD Tuccille
“Price controls and regulatory burdens make the market unattractive for pharmaceutical companies.” (02/20/26)
https://reason.com/2026/02/20/canadas-government-dominated-healthcare-chokes-access-to-new-drugs/